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Abstract
Background: miRNAs are 17–25 nucleotides long RNA molecules that have been found to regulate gene expression in
human cells. There are studies showing that different groups of miRNAs are involved in development of different tissues. In
hepatocytes there are reported particular types of miRNAs that regulate gene expression.
Methods: We established a human fetal liver cDNA library by a modified cloning protocol. Then plasmid isolation from the
colonies was performed. After sequencing and database searching, the miRNAs were recognized. RT-PCR and sequencing
were carried out to validate the miRNAs detected. Real-time PCR was used to analyze the expression of each miRNA.
Results: One novel miRNA was discovered, together with another 35 previously-known miRNAs in the fetal liver. Some of
them existed in variants. The miRNAs identified were validated by RT-PCR and sequencing. Quantitative analysis showed
that they have variable expression.
Conclusion: Our results indicate that a special group of miRNAs may play an important role in fetal liver development in a
synergistic manner.
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Introduction
The epigenetic silencing of genes after transcription can be
caused by either exogenous small interfering RNAs (siRNAs) or
endogenous microRNAs (miRNAs). The miRNAs are non-coding
RNAs which repress translations of target mRNAs. The miRNA
genes encode for primary miRNAs (pri-miRNAs). These pri-
miRNAs are trimmed into approximate 70 nucleotides of hairpin
structures, called precursor miRNAs (pre-miRNAs), by the RNase
III type protein, Drosha, in the nucleus. The pre-miRNAs are then
transported to the cytoplasm by Exportin-5 and are cleaved to 22
nucleotides of mature miRNAs by Dicer enzymes, another RNase
type III [1].
Studies show that miRNAs play a bigger role in the important
biological processes. Some miRNAs, e.g., let-7 and lin-4, can
regulate the timing of early and late larval developmental
transition in Caenorhabditis elegans [2,3]. In plants, some miRNAs
regulate flowering, leaf development and embryonic patterning
[4–6]. Furthermore, miR-14 and bantam are found to regulate
apoptosis, growth and fat metabolism in Drosophila [7,8].
The miRNAs play important roles in development and
differentiation of human organs [9–12]. Some of them exhibit
tissue-specific expression [13]. To date more than 850 human
miRNAs have been identified (miRBase database) (http://
microrna.sanger.ac.uk/index.shtml). Detection of additional miR-
NAs can be expected in the future. The usual way to find novel
miRNAs is to use a miRNA cloning method [14], which can also
identify variants for some miRNAs [15]. The miRNA variants
may have different target genes, compared to wildtype miRNAs.
The liver is a crucial human organ, in which miRNAs should be
involved in regulation of hepatocyte growth and development.
The involvement of miRNAs in fetal liver and adult liver may be
different, as miRNA expression also shows developmental stage
specificity [16]. Hitherto, only one article has reported miRNA
identification in human fetal liver: the authors did not specify the
age of the fetus [15].
In this study we identified 36 miRNAs from the liver of a
human fetus of 27 weeks by a modified cloning method. Of these
miRNAs, 35 were identical or variant to those described
previously, and one was novel.
Results and Discussion
Detection of 36 miRNAs from the cDNA library and
confirmation of miRNA expression by RT-PCR and
sequencing
A cDNA library for small RNAs (#200 nt) was constructed by a
modified cloning method. Based on a previous study [15], we
modified the 59 linker and RT primer. The 59 linker and RT
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worked well and cost less. This method has advantages that the
microarray method lacks, for example in the discoveries of novel
and variant miRNAs.
The clones were picked up from the LB plates for analysis. A
total of 143 clones were subsequently examined by DNA
sequencing and database searching. Several kinds of cellular
RNA fragments were detected (Table 1). More than 20% of the
cloned RNAs were degraded products of abundant RNAs such as
rRNA and mRNA, and 111 clones were identified as miRNAs. As
shown in Table 2, the majority are known miRNAs, and only one
is novel miRNA, which was identified by using the flanking
sequences to predict secondary structure through Mfold. As
regards the previously-known miRNAs, some were detected as
variants of miRNAs in the miRNA database (Fig. 1 and Table 2).
The novel miRNA is 33 bp, larger than the common ones. It did
not show homology with any known miRNA or other sources of
RNAs. However, the 33 bp of miRNA has an identical sequence
in the human genome and has a typical hairpin which was
predicted using Mfold (Fig. 2).
A total of 36 miRNAs were detected in this fetal liver, especially
the liver-specific miRNAs, including miR-122, miR-148, miR-192
and miR-194 [17], were all identified (Table 2). Compared to the
report by Fu et al. [15], different types of miRNAs were detected
in our study. The first reason for this difference could be that the
livers are at different stages of development, and different miRNAs
may play roles in specific periods. The second reason could be that
the number of clones examined in our study is larger than in that
study. The third explanation could be that a bias for clonal
selection emerged when we picked up the colonies on the LB
plates.
In our study, most of members of the let-7 family were identified
(Table 2); these were however, not detected at all in the study of Fu
et al [15]. The let-7 family acts as a tumour suppressor and plays a
critical role in cell-cycle control with respect to differentiation and
tumourigenesis [18]. The expression of the let-7 family detected in
the middle of the pregnancy suggests a certain level of negative
regulation of cell growth in the 27-week fetal liver.
The miRNAs identified above were confirmed by using RT-
PCR and sequencing. Figure 3 shows each miRNA was amplified,
suggesting that they were stably expressed in the fetal liver. The
RT-PCR products were then sequenced and all miRNA sequences
were found correct (Fig. 4).
Comparison of miRNA expression using real-time PCR
In order to ascertain their relative expression level, a real-time
PCR was carried out, and we found that miR-122 (p,0.0001),
miR-451 (p=0.0057) and miR-novel (p=0.0006) have a higher
level compared to others (Fig. 5), suggesting that these miRNAs
play an important role in development and differentiation of the
liver at 27 weeks. However, the other three liver-specific miRNAs
(miR-148, miR192 and miR-194) exhibited moderate expression
levels (Fig. 5). A previous study of an adult liver reported high
expression of miR-122 and miR-194, and moderate expression of
miR-148 and miR-192 [17], which is similar to our study (Fig. 5),
indicating that these liver-specific miRNAs are important for the
two developmental stages of the liver. In that study, let-7a, let-7b,
miR-21 and miR-27b also showed a moderate expression level
[17], which is in line with this study (Fig. 5).
Analysis of potential targets for the miRNAs
A prediction of target genes for the known miRNAs was
undertaken using software for miRNA targets version 5 and
TargetScan 5.1, and their target genes in the liver were predicted
(Table 3). Interestingly, some miRNAs act on the same target
genes (Table 3), suggesting that there is synergy between these
miRNAs during hepatic development. The highest expression
level was detected for miR-122, whose target genes include
PINX1_HUMAN (Table 3). This gene may inhibit cell prolifer-
ation and act as tumour suppressor [19]. It has been suggested that
inhibition of this gene may promote hepatic growth.
A novel miRNA was also detected in this liver organ, which is
larger than the previously described miRNAs. Its predicted target
genes in the liver organ are LEAP2 (liver expressed antimicrobial
peptide 2) and DLC1 (deleted in liver cancer 1) (Table 3). It is
suggested that DLC1 is a candidate tumour suppressor gene for
human liver cancer, as well as for prostate, lung, colorectal and
breast cancers [20]. Larger miRNAs (dan-mir-289: 35 bp) have
been identified in Drosophila (miRBase database). These have not
been detected in human before.
Interestingly, the variants for some miRNAs were found, including
single-nucleotide substitution and length difference (Fig. 1 and
Table 2). Some of them were also analysed by RT-PCR and real-time
PCR (Fig. 3 and Fig. 5). Specially, the variants with 3 and 4 bases
longer for miR-451 were also analysed using RT-PCR and real-time
PCR, and found to have stable expression (data not shown). We
speculate that the single-nucleotide substitution is due to the post-
transcriptional modifications, e.g. A-to-I editing (identified as A-to-G
changes) [21] or the single-nucleotide polymorphism (SNP) in the
miRNA genes [22], and length difference to alternative cleavage of
the hairpins by the Dicer enzymes, because in the majority of
miRNAs the bases added were found to be next to the mature
sequences in the hairpin secondary structures. We can exclude that
the variants are generated by PCR and/or sequencing errors,
because our RT-PCR amplified all of the variants. The length
difference has also been identified in the cDNA library for silkworm
miRNAs [23]. It is conceivable that these variants have different
target genes; thus certain types of miRNAs could inhibit multiple
target genes. For example, five variants have been identified for miR-
451 (Fig. 1). It can be speculated that these variants act on different
target genes compared to the wildtype of miR-451.
Conclusions
Our results showed that a special group of miRNAs have been
expressed in the fetal liver of 27 weeks. These discoveries help shed
light on the fine-tuning mechanism of miRNAs in hepatocyte
development and differentiation. Further studies are needed in
order to identify the exact target genes of these miRNAs.
Table 1. Composition of small RNA populations cloned from
fetal liver.
RNA class Number
miRNA 111
mRNA 12
rRNA 8
Match with genome
a 10
Unknown
b 2
Total 143
aSequences that do not form miRNA-specific hairpin precursors but only match
with genomic sequences.
bSequences that do not match with any genomic sequences.
doi:10.1371/journal.pone.0007594.t001
miRNAs in Fetal Liver
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miRNA Sequence (59–39) No. clones Size(nt)
hsa-let-7a UGAGGUAGUAGGUUGUAUAGU 1 21
hsa-let-7b UGAGGUAGUAGGUUGUGUGGUU 1 22
hsa-let-7c UGAAGUAGUACGUUGUAGGGUU 1 22
hsa-let-7d AGAGGUAGUAGGUUGCAUAGUU 1 22
hsa-let-7f UGAGGUAGUAGAUUGUAUAGUU 2 22
hsa-let-7g UGAGGUAGUAGUUUGUACAGUU 1 22
hsa-miR-15a UAGCAGCACAUCAUGGUUUGU 2 21
hsa-miR-19a UGUGCAAAUCUAUGCAAAACUGA 1 23
hsa-miR-19b UGUGCAAAUCCAUGCAAAACUGA 2 23
hsa-miR-21 UAGCUUAUCAGACUGAUGUUGA 1 22
UAGCUUAUCAGACUGAUGUUGAC 1 23
hsa-miR-23a AUCACAUUGCCAGGGAUUCCC 1 21
hsa-miR-24 UGGCUCAGUUCAGCAGGAACAG 2 22
UGGCUCAGUUCAGCAGGAAC 1 20
UGGCUCAGUUCAGCAGGAACAGAU 1 24
hsa-miR-26a UUCAAGUAAUCCAGGAUAGGC 1 21
hsa-miR-26b UUCAAGUAAUUCAGGAUAG 1 19
UUCAAGUAAUUCAGGAUAGGU 1 21
hsa-miR-27a UUCACAGUGGCUAAGUUCCGC 1 21
hsa-miR-27b UUCACAGUGGCUAAGUUCUGC 1 21
hsa-miR-30d UGUAAACAUCCCCGACUGGAAG 1 22
hsa-miR-30e
* CUUUCAGUCGGAUGUUUAC 1 19
hsa-miR-98 UGAGGUAGUAAGUUGUAUUG 1 20
hsa-miR-99a GACCCGUAGAUCCGAUCUUGUG 1 22
hsa-miR-101 GUACAGUACUGUGAUAACUGAA 1 22
hsa-miR-103 AGCAGCAUUGUACAGGGCUAUGA 1 23
hsa-miR-122 UGGAGUGUGACAAUGGUGUU 4 20
UGGAGUGUGACAAUGGUGUUU 7 21
UGGAGUGUGACAAUGGUGUUUG 39 22
GUGGAGUGUGACAAUGGUGUUUG 1 23
hsa-miR-125a-5p UCCCUGAGACCCUUUAACCUGU 1 22
hsa-miR-126 UCGUACCGUGAGUAAUAAUGCG 2 22
hsa-miR-136 ACUCCAUUUGUUUUGAUGAAGGA 1 23
hsa-miR-144 UACAGUAUAGAUGAUGUACU 1 20
hsa-miR-148a UCAGUGCACUACAGAACUUUGU 2 22
UCAGUGCACUACAGAACUUUGUC 1 23
hsa-miR-192 CUGACCUAUGAAUUGACAGCC 1 21
CUGACCUAUGAAUUGACAGC 2 20
hsa-miR-194 UGUAACAGCAACUCCAUGUGGA 3 22
hsa-miR-410 AAUAUAACACAGAUGGCCUGU 1 21
hsa-miR-451 AAACCGUUACCAUUACUGAGU 1 21
AAACCGUUACCAUUACUGAGUU 1 22
AACCGUUACCAUUACUGAGUUU 1 22
AAACCGUUACCAUUACUGAGUUU 4 23
AAACCGUUACCAUUACUGAGUUUAG 1 25
AAACCGUUACCAUUACUGAGUUUAGU 2 26
hsa-miR-483-3p UCACUCCUCUCCUCCCGUCUUC 1 22
hsa-miR-483-5p AGACGGGAGGAAAGAAGGGAGUGG 1 24
hsa-miR-885-5p UCCAUUACACUACCCUGCCUAU 1 22
hsa-miR-novel AGCAUUGGUGGUUCAGUGGUAGAAUUCUCGCCU 2 33
total / 111 /
doi:10.1371/journal.pone.0007594.t002
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Ethics Statement
This research has been approved by the review board of Huazhong
University of Science and Technology. We obtained tissue samples
with written informed consent from the participant involved in the
study. The ethics committee specifically approved that procedure.
Isolation of small RNA
The liver tissue was obtained from a female fetus of 27 weeks
delivered due to severe syndrome of high blood pressure of the
mother in Tongji hospital, Wuhan, Hubei, China. The fetus died
shortly after delivery. The mother of the fetus had no other
diseases than high blood pressure. Small RNA (#200 nt) was
isolated from the liver tissue using a mirVana
TM miRNA isolation
Figure 2. Predicted secondary structure of primary miRNA for the novel miRNA identified. The bases highlighted in red represent mature
miRNA.
doi:10.1371/journal.pone.0007594.g002
Figure 1. Variants detected for some miRNAs. The difference between miRNAs from the database (d) and the cloned (c) is highlighted in red.
doi:10.1371/journal.pone.0007594.g001
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tions. About fifty milligrams of tissue were used and the small
RNA was eluted in 100 ml RNase-free water. The RNA
concentration was tested by UV absorbance at 260 nm.
Establishment and screen of cDNA library
The RNAs above were polyadenylated at 37uC for 30 min in
50 ml reaction volume using ,1 mg RNA and 5 U poly(A)
polymerase (New England Biolabs). Then the Poly(A)-tailed small
RNA was purified through phenol/chloroform extraction and
ethanol precipitation. A 59 linker (59-GGA CAC UGA CAU GGA
CUG AAG GAG UAG AAA-39) was ligated to poly(A)-tailed
RNA using T4 RNA ligase (New England Biolabs) and the ligation
products were recovered by phenol/chloroform extraction fol-
lowed by ethanol precipitation. Reverse transcription was
conducted using the entire poly(A)-tailed RNA and 1 mgR T
primer (59-CGC TAC GTA ACG GCA TGA CAG TG (T)24-39)
with 200 U of SuperScript III reverse transcriptase (Invitrogen)
according to the manufacturer’s instructions. The cDNA was
amplified for 35 cycles at an annealing temperature of 55uC using
primers 59-GGA CAC TGA CAT GGA CTG AAG GAG TA-39
and 59-CGC TAC GTA ACG GCA TGA CAG TG-39. The PCR
products were run on 3% agarose gel with GoldView staining.
Then the gel slices with DNA of a size about 110 bp were excised
and purified using EasyPure quick gel extraction kit (TransGen
Biotech). The DNA fragments were directly cloned into pEASY-
T1 vector (TransGen Biotech). Colony PCR was performed using
59 and 39 primers, and the clones with PCR products about
110 bp in length were sequenced.
Validation of miRNA expression by RT-PCR and
sequencing
Reverse transcription was carried out using ,1 mg poly(A)-
tailed small RNA and 1 mg of the same RT primer as above with
200 U of SuperScript III (Invitrogen) according to the method
described above. Amplification of miRNA was conducted for 35
cycles at an annealing temperature of 55uC using miRNA-specific
forward primers (Table 4) and reverse primer (59-CGC TAC GTA
ACG GCA TGA CAG TG-39). The internal control was U6 small
nuclear RNA, because U6 is stably expressed in human tissues.
The PCR products were separated on 3% agarose gel with
GoldView staining. Then the PCR bands were excised and
purified. The purified PCR products were cloned into pEASY-T1
vector (TransGen Biotech), and clones with PCR products were
sequenced.
miRNA quantitative analysis using real-time PCR
Real-time PCR was carried out in a Stratagene MX-4000
system with the same primers as detection of miRNA expression
by RT-PCR and TransStart SYBR green qPCR supermix
Figure 4. Sequencing of the RT-PCR products for 6 miRNAs.
doi:10.1371/journal.pone.0007594.g004
Figure 3. RT-PCR for miRNAs. Positive control is U6 small nuclear RNA. H2O serves as negative control.
doi:10.1371/journal.pone.0007594.g003
miRNAs in Fetal Liver
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doi:10.1371/journal.pone.0007594.g005
Table 3. Prediction of target genes of miRNAs identified.
miRNAs Target genes in human liver
hsa-let-7a PRDX5
hsa-let-7b PRDX5, NP_060880.3, CPT1A
hsa-let-7c NP_060880.3, CPT1A
hsa-let-7d GJB1
hsa-let-7f CPT1A, TMEM59
hsa-let-7g PFKFB1, PRDX5
hsa-miR-15a GLS2, PFKFB1
hsa-miR-19a PSG1, DLC1
hsa-miR-19b PSG1
hsa-miR-21 PHKA2, CCL20, GJB1, PYGL
hsa-miR-23a PTP4A2, ARG1
hsa-miR-24 PHLDA2, DNASE1L3, PSG5, PINX1_HUMAN
hsa-miR-26a TMEM59
hsa-miR-26b TMEM59
hsa-miR-27a PFKL, PFKFB1, COX8A, NP_060880.3
hsa-miR-27b PFKL, PFKFB1, COX8A, NP_060880.3
hsa-miR-30d N.D.
hsa-miR-30e
* PRDX5
hsa-miR-98 PRDX5, Q6SA06_HUMAN
hsa-miR-99a STARD13, COX6A1
hsa-miR-101 PFKFB1
hsa-miR-103 PHKG2, Q86U10_HUMAN, GLS2
hsa-miR-122 PKLR, ALPL, PINX1_HUMAN, PSG5
hsa-miR-125a-5p NR5A2, STARD13
hsa-miR-126 CSTB
hsa-miR-136 PBLD, PYGL, STARD13, TMEM59
hsa-miR-144 ALDOB, CCL20
hsa-miR-148a PKLR, PHKG2
hsa-miR-192 PTP4A3, TM4SF4, HAMP, COX7A2
hsa-miR-194 N.D.
hsa-miR-410 PSG1, TMEM59, CLEC4M
hsa-miR-451 TMEM59
hsa-miR-483-3p OSGIN1, GJB1, DLC1
hsa-miR-483-5p PTP4A3, HAMP, GFER
hsa-miR-885-5p Q86U10_HUMAN
hsa-miR-novel LEAP2, DLC1
N.D., no data.
doi:10.1371/journal.pone.0007594.t003
Table 4. miRNA specific primers for RT-PCR and real-time
PCR.
miRNA primer
hsa-let-7a TGAGGTAGTAGGTTGTATAGT
hsa-let-7b TGAGGTAGTAGGTTGTGTGGTT
hsa-let-7c TGAAGTAGTACGTTGTAGGGTT
hsa-let-7d AGAGGTAGTAGGTTGCATAGTT
hsa-let-7f TGAGGTAGTAGATTGTATAGTT
hsa-let-7g TGAGGTAGTAGTTTGTACAGTT
hsa-miR-15a TAGCAGCACATAATGGTTTGT
hsa-miR-19a TGTGCAAATCTATGCAAAACTG
hsa-miR-19b TGTGCAAATCCATGCAAAACTG
hsa-miR-21 TAGCTTATCAGACTGATGTTG
hsa-miR-23a ATCACATTGCCAGGGATTCC
hsa-miR-24 TGGCTCAGTTCAGCAGGAACAG
hsa-miR-26a TTCAAGTAATCCAGGATAGG
hsa-miR-26b TTCAAGTAATTCAGGATAG
hsa-miR-27a TTCACAGTGGCTAAG TTCC
hsa-miR-27b TTCACAGTGGCTAAGTTCTGC
hsa-miR-30d TGTAAACATCCCCGACTGGAAG
hsa-miR-30e
* CTTTCAGTCGGATGTTTAC
hsa-miR-98 TGAGGTAGTAAGTTGTATTG
hsa-miR-99a GACCCGTAGATCCGATCTTGTG
hsa-miR-101 TACAGTACTGTGATAACTGAA
hsa-miR-103 AGCAGCATTGTACAGGGCTATG
hsa-miR-122 TGGAGTGTGACAATGGTGTTTG
hsa-miR-125a-5p TCCCTGAGACCCTTTAACCTGT
hsa-miR-126 TCGTACCGTGAGTAATAATG
hsa-miR-136 ACTCCATTTGTTTTGATGAAGG
hsa-miR-144 TACAGTATAGATGATGTACT
hsa-miR-148a TCAGTGCACTACAGAACTTTGT
hsa-miR-192 CTGACCTATGAATTGACAGC
hsa-miR-194 TGTAACAGCAACTCCATGTGG
hsa-miR-410 AATATAACACAGATGGCCTGT
hsa-miR-451 AAACCGTTACCATTACTGAGTT
hsa-miR-483-3p TCACTCCTCTCCTCCCGTCTT
hsa-miR-483-5p AGACGGGAGGAAAGAAGGGAGTGG
hsa-miR-885-5p TCCATTACACTACCCTGCCTAT
hsa-miR-novel GGTGGTTCAGTGGTAGAATTCTC
doi:10.1371/journal.pone.0007594.t004
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The 20 ml reactions including 0.5 ml of RT products, 1x
TransStart SYBR green qPCR supermix and 0.5 mM forward
and reverse primers were incubated at 95uC for 5 min, followed
by 40 cycles of 95uC for 10 sec, 55uC for 15 sec and 72uC for
20 sec. The amplification curves (Fig. S1) were examined and no
differences of PCR efficiencies between the reactions were seen.
Melting curves for each PCR were carefully monitored to avoid
non-specific amplification. The U6 small nuclear RNA was used
as internal control. Each miRNA was analysed in duplicate.
Relative level (RL) of each miRNA expression was calculated with
2
2DCt method, and the data were presented as log2 of RL of target
miRNAs. Results were visualized with GENESIS (Alexander
Sturn, Institute for Genomics and Bioinformatics, Graz University
of Technology).
Biological software analysis
The small RNA sequences were analysed using BLAST analysis
against the human genome and miRNA databases. The secondary
structures of RNA precursors were built by using longer genomic
sequences of cloned RNAs and the Mfold program (http://mfold.
bioinfo.rpi.edu/cgi-bin/rna-form1.cgi).
Statistical analysis of miRNA expression
A two-tailed t-test was used to assess the expression level
difference between miRNA and U6.
Target gene prediction of each miRNA
Target genes for each miRNA were predicted using miRBase
Targets Version 5 program (http://microrna.sanger.ac.uk/
targets/v5/) and TargetScan 5.1 program (http://www.targetscan.
org/).
Supporting Information
Figure S1 The amplification plots for real-time PCR.
Found at: doi:10.1371/journal.pone.0007594.s001 (0.11 MB
DOC)
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